コンテンツへスキップ
Merck
  • Hematogenous macrophage depletion reduces the fibrotic scar and increases axonal growth after spinal cord injury.

Hematogenous macrophage depletion reduces the fibrotic scar and increases axonal growth after spinal cord injury.

Neurobiology of disease (2014-12-03)
Y Zhu, C Soderblom, V Krishnan, J Ashbaugh, J R Bethea, J K Lee
要旨

Spinal cord injury (SCI) leads to formation of a fibrotic scar that is inhibitory to axon regeneration. Recent evidence indicates that the fibrotic scar is formed by perivascular fibroblasts, but the mechanism by which they are recruited to the injury site is unknown. Using bone marrow transplantation in mouse model of spinal cord injury, we show that fibroblasts in the fibrotic scar are associated with hematogenous macrophages rather than microglia, which are limited to the surrounding astroglial scar. Depletion of hematogenous macrophages results in reduced fibroblast density and basal lamina formation that is associated with increased axonal growth in the fibrotic scar. Cytokine gene expression analysis after macrophage depletion indicates that decreased Tnfsf8, Tnfsf13 (tumor necrosis factor superfamily members) and increased BMP1-7 (bone morphogenetic proteins) expression may serve as anti-fibrotic mechanisms. Our study demonstrates that hematogenous macrophages are necessary for fibrotic scar formation and macrophage depletion results in changes in multiple cytokines that make the injury site less fibrotic and more conducive to axonal growth.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ジメチルスルホキシド, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
テトラヒドロフラン, inhibitor-free, suitable for HPLC, ≥99.9%
Sigma-Aldrich
ジメチルスルホキシド, ACS reagent, ≥99.9%
Sigma-Aldrich
ジメチルスルホキシド, Molecular Biology
Sigma-Aldrich
ジメチルスルホキシド, suitable for HPLC, ≥99.7%
Sigma-Aldrich
ジメチルスルホキシド, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
ジメチルスルホキシド, ReagentPlus®, ≥99.5%
Sigma-Aldrich
テトラヒドロフラン, contains 200-400 ppm BHT as inhibitor, ACS reagent, ≥99.0%
Sigma-Aldrich
ジメチルスルホキシド, anhydrous, ≥99.9%
Sigma-Aldrich
テトラヒドロフラン, anhydrous, ≥99.9%, inhibitor-free
Sigma-Aldrich
テトラヒドロフラン, anhydrous, contains 250 ppm BHT as inhibitor, ≥99.9%
Sigma-Aldrich
ジメチルスルホキシド, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
ジメチルスルホキシド, puriss. p.a., ACS reagent, ≥99.9% (GC)
Sigma-Aldrich
ベンジルアルコール, ReagentPlus®, ≥99%
Sigma-Aldrich
ベンジルアルコール, ACS reagent, ≥99.0%
Supelco
ベンジルアルコール, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
抗ラミニン ウサギ宿主抗体, 0.5 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
ジメチルスルホキシド, BioUltra, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
テトラヒドロフラン, ≥99.0%, contains 200-400 ppm BHT as inhibitor, ReagentPlus®
USP
ベンジルアルコール, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
テトラヒドロフラン, contains 250 ppm BHT as inhibitor, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99.9%
Sigma-Aldrich
ベンジルアルコール, puriss., meets analytical specification of Ph. Eur., BP, NF, 99-100.5% (GC)
Sigma-Aldrich
ジメチルスルホキシド, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
ベンジルアルコール, anhydrous, 99.8%
Sigma-Aldrich
テトラヒドロフラン, ACS reagent, ≥99.0%, contains 200-400 ppm BHT as inhibitor
Sigma-Aldrich
ジメチルスルホキシド, PCR Reagent
Sigma-Aldrich
ベンジルアルコール, puriss. p.a., ACS reagent, ≥99.0% (GC)
Sigma-Aldrich
安息香酸ベンジル, ReagentPlus®, ≥99.0%
Sigma-Aldrich
ジメチルスルホキシド, puriss. p.a., dried, ≤0.02% water